By Casey Walters - May 1, 2013 | Tickers: ARNA, BIIB, BPAX, CELG | 0 Comments
Casey is a member of The Motley Fool Blog Network -- entries represent the personal opinion of the blogger and are not formally edited.
Bio stocks can be a gamble. When they fall, companies in this particular industry can fall hard, especially if the news is really bad or expectations were hyped beyond reality. A few months ago, Peregrine Pharmaceuticals dropped 78% in one day after the company disclosed that its stellar Phase II data for lung cancer drug bavituximab was not valid.
Does that mean bio stocks are a no-go?' Far from it, but in order to do invest effectively, one needs to remember there are a few steps you can take to increase your chances of making money and, more importantly, not losing it all after one press release hits the wires.
Spreading your bets is essential. Its easy to be tempted to put money in just one or two names and dream of buying your own island in the Pacific after the company cures cancer. But unless youre incredibly lucky, it doesnt often work out that way. Picking five or even ten bio companies will reduce the damage to your portfolio should one go down as well as increase your chances of holding a winner.
Second, take the lead from big investors. Julian and Felix Baker manage money for the Tisch Family and invest primarily in biotech. One has a Ph.D. in immunology from Stanford, the other studied business at Harvard. They have had successful early positions in big winners like Seattle Genetics and Pharmasset the latter was acquired by Gilead Sciences for $137 per share.
Finally, do your own research. Take the names that some analysts throw out and dig into the news. Heres my top five, but again, see for yourself!
1.) Biogen Idec
Biogen (NASDAQ: BIIB) is an established company with solid revenue. It already has multiple sclerosis drugs that are positioned as leaders in that market. Now, its new MS pill, Tecfidera, will be priced at a wholesale acquisition cost of $54,900 per patient per year. The medicine will distributed, stocked, and available to patients this month according to company spokespeople. This is going to blow sales sky-high as people have trusted the Biogen brand. Even before this news, shares were already up over 33% so far in 2013. Biogen also has some exciting drugs in the pipeline which include a Chronic Lymphocytic Leukemia and a Non-Hodgkin's Lymphoma in phase 3 testing. The Chronic Lymphocytic Leukemia, is dominated only by 4 companies. With Ambit Biosciences bringing in an estimated $21,000 per patient annually. Biogen's new more effective drug would be expected to bring in this amount per patient and with the druge being more effective this will cut into their competitors market share.
2.) Celgene
Read the original post:
- The truth about guys and sex: They fake it, too - April 29th, 2013 [April 29th, 2013]
- Rock-It Man male sexual performance drug recalled - April 29th, 2013 [April 29th, 2013]
- Judge approves class-action lawsuit over erectile dysfunction link to prostate, baldness drugs - April 29th, 2013 [April 29th, 2013]
- Apricus, Innovus tackle bedroom disorders - April 29th, 2013 [April 29th, 2013]
- Ask Dr. K: Precautions for male bicyclists - April 29th, 2013 [April 29th, 2013]
- Advanced Male Medical Center Announces Hiring of Erick Salazar - April 29th, 2013 [April 29th, 2013]
- Faking the big O - April 29th, 2013 [April 29th, 2013]
- Priapus Shot - Video - April 29th, 2013 [April 29th, 2013]
- Trimel Submits New Drug Application for CompleoTRT(TM) to FDA - April 30th, 2013 [April 30th, 2013]
- Class-Action Lawsuit on Propecia Erectile Dysfunction Approved: Now, AttorneyOne Can Provide Advice - May 3rd, 2013 [May 3rd, 2013]
- Trimel to Report First Quarter 2013 Results and Host Investor Call - May 3rd, 2013 [May 3rd, 2013]
- Acupuncture Presentation Part 2 - Video - May 6th, 2013 [May 6th, 2013]
- Sixty-One Per Cent of Women Say their Sex Lives are Suffering Due to a Condition of Menopause - May 7th, 2013 [May 7th, 2013]
- Apricus Biosciences Announces Poster Presentation of Vitaros(R) Data in Men Previously Unresponsive to PDE-5 ... - May 8th, 2013 [May 8th, 2013]
- Dietary Supplement Lightning Rod Capsules Recall - May 8th, 2013 [May 8th, 2013]
- Apricus Biosciences Announces First Quarter 2013 Financial Results Conference Call - May 8th, 2013 [May 8th, 2013]
- BioSante Pharmaceuticals and ANI Pharmaceuticals Announce Special Meetings of Stockholders to Consider Proposed Merger - May 9th, 2013 [May 9th, 2013]
- Why Wait? Enlast Personal Male Lubricant. Stop Premature Ejaculation In Its Tracks With Enlast.flv - Video - May 9th, 2013 [May 9th, 2013]
- Searching For Male Fountain of Youth? Go Exercise - May 11th, 2013 [May 11th, 2013]
- BioSante Pharmaceuticals, Inc. Reports First Quarter Financial Results - May 11th, 2013 [May 11th, 2013]
- Apricus Biosciences Provides First Quarter 2013 Corporate Update - May 11th, 2013 [May 11th, 2013]
- DGAP-News: Apricus Biosciences Provides First Quarter 2013 Corporate Update - May 11th, 2013 [May 11th, 2013]
- Sex and the elderly male - May 12th, 2013 [May 12th, 2013]
- Couple sues state over toddler's sexual-reassignment surgery - May 15th, 2013 [May 15th, 2013]
- Columbia couple sues state over toddler’s sexual-reassignment surgery - May 15th, 2013 [May 15th, 2013]
- If Sexual Dysfunction Were a Virus, "It'd Be Pandemic": Expert - May 16th, 2013 [May 16th, 2013]
- Couple files groundbreaking lawsuit over child’s sexual-reassignment surgery - May 16th, 2013 [May 16th, 2013]
- The Dangers Lurking in Male Sexual Supplements - May 17th, 2013 [May 17th, 2013]
- West Jordan man pleads guilty to falsely advertising, selling Viagra-like drug - May 17th, 2013 [May 17th, 2013]
- Manning up to the church - May 20th, 2013 [May 20th, 2013]
- Boy who manned up to the church - May 20th, 2013 [May 20th, 2013]
- The low-down on erectile problems - May 21st, 2013 [May 21st, 2013]
- Study: Genital Warts May Lead to Sexual Dysfunction; polyDNA Recommends Gene-Eden-VIR Against the Genital Warts Virus - May 22nd, 2013 [May 22nd, 2013]
- Quit smoking for a better sex life - study - May 22nd, 2013 [May 22nd, 2013]
- If It Doesn’t Make Us Nymphos, Female Viagra Will Save Monogamy - May 23rd, 2013 [May 23rd, 2013]
- Erectile dysfunction drugs sold as herbal medicine - May 24th, 2013 [May 24th, 2013]
- Heart failure ups risk of male menopause 4 fold - May 25th, 2013 [May 25th, 2013]
- Heart failure accelerates male 'menopause' - May 25th, 2013 [May 25th, 2013]
- New Asia-Pacific Sexual Satisfaction Study Pulls Back the Covers on Relationship Tension Facing Couples - May 28th, 2013 [May 28th, 2013]
- Heart Disease Accelerates Male Menopause - May 29th, 2013 [May 29th, 2013]
- Igniting woman's sexual desire is more than popping pill - May 30th, 2013 [May 30th, 2013]
- Warning: 'Natural' sex supplements may not be - May 31st, 2013 [May 31st, 2013]
- Dangers of sex supplements - May 31st, 2013 [May 31st, 2013]
- Warning: Men's natural sex supplements may not be - May 31st, 2013 [May 31st, 2013]
- Sex is doctor's life's work - June 1st, 2013 [June 1st, 2013]
- Sex is life's work for doctor - June 3rd, 2013 [June 3rd, 2013]
- Sexual stress common in men - June 6th, 2013 [June 6th, 2013]
- Sexual performance anxiety - June 6th, 2013 [June 6th, 2013]
- Affirm XL, Inc. Re-launches U.S. Made Sexual Enhancement Dietary Supplement - June 6th, 2013 [June 6th, 2013]
- Apricus Biosciences Receives European Approval for Vitaros(R) for the Treatment of Erectile Dysfunction - June 11th, 2013 [June 11th, 2013]
- DGAP-News: Apricus Biosciences Receives European Approval for Vitaros(R) for the Treatment of Erectile Dysfunction - June 11th, 2013 [June 11th, 2013]
- BPA linked to obesity risk in puberty-age girls - June 13th, 2013 [June 13th, 2013]
- Baldness drug curbs interest in alcohol, study says- Fla. mom dies after butt enhancing injections - June 14th, 2013 [June 14th, 2013]
- Anti-baldness drug can cause men to lose interest in alcohol - June 14th, 2013 [June 14th, 2013]